Lymphomas

This focused talk will provide radiation oncologists with the up-to-date management of patients with lymphoma, including clinical decision making on who benefits from radiotherapy, the optimal dose/fractionation, and technical aspects of treatment including involved site/node radiotherapy and advanced radiation techniques. New trial data will be put in context with existing treatment paradigms, thereby providing attendees a framework on how radiotherapy for lymphoma is integrated with systemic therapies (if applicable) and diagnostic imaging, including PET/CT. Case-based studies will be integrated throughout the talk to highlight the potential role of modern radiation techniques to minimize radiation toxicity.

Target Audience

The meeting is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, nurses and all other health professionals involved in the field of radiation oncology.

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Recognize the key role of radiotherapy in management of patients with lymphoma, including in the primary, adjuvant, salvage, and palliative settings.
  • Describe how radiotherapy for patients with lymphoma interfaces with systemic therapy in the era of PET.
  • Outline strategies to minimize radiation toxicity, including involved site/node radiotherapy and advanced radiation techniques.

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
03/20/2021
Course expires: 
03/23/2024
Cost:
$0.00
Rating: 
0

Yolanda Tseng, MD is employed by the University of Washington and has no financial relationships with a commercial interest.

All relevant relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

 

 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.